Le Lézard
Classified in: Health
Subject: FDA

FDA Approves Smilekey®, a Much Anticipated Smileloc® Induction Remover Device by Rodo Medical, Inc.


SAN JOSE, Calif., June 4, 2018 /PRNewswire/ -- Rodo Medical, Inc., an innovative dental device company, announces FDA 510(k) clearance of the Rodo Smilekey, an induction remover device for use with the Rodo Abutment System. 

The Smilekey uses Rodo's proprietary induction technology to remove dental prostheses retained by the Rodo Smileloc in less than 10 seconds without occlusal holes or damaging the prostheses.  The Smilekey greatly enhances the patient and practitioner experience with the Rodo Abutment System by providing safe and easy removal of single-tooth restorations and multi-unit-prostheses.  This fast, easy, and safe removal of prostheses enables the dentist to provide optimal treatment options and maintenance schedules for patients with implants without incurring excessive chair time and the complications typically associated with screw-retained or cemented prostheses.

As part of the FDA clearance, the Smilekey underwent numerous safety tests including thermal and electrical safety testing, electromagnetic compatibility testing, and functional testing with various restorative materials and sizes of restorations.

The Smilekey will be available initially to current Rodo customers in July 2018, and then to the broader US market and other select countries later this year. For more information, please contact Veronika Jedlicka, Director of Customer Experience at [email protected].

About Rodo Medical, Inc.
Rodo Medical is an innovative dental device company dedicated to improving restorative procedures for patients and dentists with its novel retention and removal devices.  Rodo Medical is a privately held company based in San Jose, CA.  For more information, please visit www.rodomedical.com

Media Contact: Veronika Jedlicka, Rodo Medical, Inc., 408.245.7636, [email protected]

 

SOURCE Rodo Medical, Inc.


These press releases may also interest you

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

4 mai 2024
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

4 mai 2024
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: